State of Wyoming’s Moderna MRNA Stock Holding History

State of Wyoming’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,670	Closed	-$136K	–	2126
2026 Q1	$136K	Sell	2,670 -362	-12%	-$16.9K	0.02%	1154
2025 Q4	$89.4K	Buy	3,032 +920	+44%	+$25K	0.01%	1330
2025 Q3	$54.6K	Sell	2,112 -1,295	-38%	-$36.1K	0.01%	1550
2025 Q2	$94K	Buy	+3,407	New	+$89.7K	0.01%	1329
2023 Q3	–	Sell	-823	Closed	-$100K	–	1735
2023 Q2	$100K	Buy	+823	New	+$110K	0.03%	849
2022 Q4	–	Sell	-209	Closed	-$25K	–	1695
2022 Q3	$25K	Sell	209 -756	-78%	-$115K	0.01%	1238
2022 Q2	$138K	Sell	965 -566	-37%	-$80.9K	0.09%	298
2022 Q1	$264K	Buy	1,531 +614	+67%	+$103K	0.13%	106
2021 Q4	$233K	Sell	917 -7	-0.8%	-$2.05K	0.11%	173
2021 Q3	$356K	Buy	924 +701	+314%	+$259K	0.23%	61
2021 Q2	$52K	Buy	+223	New	+$39.9K	0.03%	735

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State of Wyoming's MRNA Position: Q2 2026 in Review

State of Wyoming sold out of Moderna (MRNA) in Q2 2026, closing a stake of 2,670 shares — an estimated $136K sold.

State of Wyoming first reported a position in MRNA in Q2 2021 and held it in 11 quarters. The position peaked at $356K in Q3 2021. 364 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

State of Wyoming reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
State of Wyoming sold 2,670 Moderna shares in Q2 2026, an estimated $136K.
State of Wyoming first reported a position in Moderna in Q2 2021 and held it in 11 quarters.
State of Wyoming's Moderna position peaked at $356K in Q3 2021.
364 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.